Andujar P, Simon-Deckers A, Galateau-Sallé F, Fayard B, Beaune G, Clin B, Billon-Galland MA, Durupthy O, Pairon JC, Doucet J, Boczkowski J, Lanone S. Role of metal oxide nanoparticles in histopathological changes observed in the lung of welders. Part Fibre Toxicol. 2014 May 13;11:23. IF:6.987
———————————————————————————————————————————————————
Angevin E, Tabernero J, Elez E, Cohen SJ, Bahleda R, van Laethem JL, Ottensmeier C, Lopez-Martin JA, Clive S, Joly F, Ray-Coquard I, Dirix L, Machiels JP, Steven N, Reddy M, Hall B, Puchalski TA, Bandekar R, van de Velde H, Tromp B, Vermeulen J, Kurzrock R. A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res. 2014 Apr 15;20(8):2192-204. IF:8.722
———————————————————————————————————————————————————
Audigier-Valette C, Girard N, Cortot AB, Mennecier B, Debieuvre D, Planchard D, Zalcman G, Moro-Sibilot D, Cadranel J, Barlesi F. [ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]. Bull Cancer. 2014 Sep;101(9):823-31. IF:0.635
———————————————————————————————————————————————————
Babin E, Grandazzi G. Cooperation between Medicine and Sociology in Head and Neck Oncology. Otolaryngol Head Neck Surg. 2014 Jan 31. IF:1.721
———————————————————————————————————————————————————
Babin E, Heutte N, Grandazzi G, Prévost V, Robard L. Quality of life and supportive care in head and neck cancers. Bull Cancer. 2014 May 1;101(5):505-510. IF:0.635
———————————————————————————————————————————————————
Baldi I, Lebailly P, Bouvier G, Rondeau V, Bouchart V, Canal-Raffin M, Garrigou A. 0345 Pesticide exposure during re-entry tasks and harvesting in vineyards: results of the pestexpo program. Occup Environ Med. 2014 Jun;71 Suppl 1:A42. IF:1.63
———————————————————————————————————————————————————
Baldi I, Robert C, Piantoni F, Tual S, Bouvier G, Lebailly P, Raherison C. Agricultural exposure and asthma risk in the AGRICAN French cohort. Int J Hyg Environ Health. 2014 Apr-May;217(4-5):435-42. IF:3.276
———————————————————————————————————————————————————
Baldi I, Lebailly P, Bouvier G, Rondeau V, Kientz-Bouchart V, Canal-Raffin M, Garrigou A. Levels and determinants of pesticide exposure in re-entry workers in vineyards: Results of the PESTEXPO study.Environ Res. 2014 Jul;132:360-9. IF:3.951
———————————————————————————————————————————————————
Baldi I, Carles C, Cantagrel A, Lecluse Y, Niez E, Fabbro-Peray P, Lebailly P. 0278 The PESTIMAT program: development of a crop exposure matrix for pesticide exposure assessment in agriculture0278 The PESTIMAT program: development of a crop exposure matrix for pesticide exposure assessment in agriculture. Occup Environ Med. 2014 Jun;71 Suppl 1:A35. IF:1.63
———————————————————————————————————————————————————
Beau-Faller M, Prim N, Ruppert AM, Nanni-Metéllus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Crémoux P, Solassol J, de Fraipont F, Bièche I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Legrain M, Voegeli AC, Baudrin L, Morin F, Zalcman G, Quoix E, Blons H, Cadranel J. Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network. Ann Oncol. 2014 Jan;25(1):126-31. IF:6.578
———————————————————————————————————————————————————
Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG7, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J. A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting–IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms. J Mol Diagn. 2014 Jan;16(1):45-55. IF:3.955
———————————————————————————————————————————————————
Béchade C, Guittet L, Evans D, Verger C, Ryckelynck JP, Lobbedez T. Early failure in patients starting peritoneal dialysis: a competing risks approach. Nephrol Dial Transplant. 2014 Nov;29(11):2127-35. IF:3.488
———————————————————————————————————————————————————
Béchade C, Daireaux G, Henri P, Landru I, Batho JM, Hurault de Ligny B, Lobbedez T. [Who is the physician in charge with the primary care of the dialysis patients?]. [Article in French] Nephrol Ther. 2014 Apr;10(2):106-11. IF:0.553
———————————————————————————————————————————————————
Bensefa-Colas L, Telle-Lamberton M, Paris C, Faye S, Stocks SJ, Luc A, Bourrain JL, Crépy MN, Dupas D, Frimat P, Garnier R, Lehucher-Michel MP, Pairon JC, Soulat JM, Lasfargues G, Choudat D; French National Network of Occupational Disease Vigilance Prevention (RNV3P), Momas I. Occupational allergic contact dermatitis and major allergens in France: temporal trends for the period 2001-2010. Br J Dermatol. 2014 Dec;171(6):1375-85. IF:4.1
———————————————————————————————————————————————————
Bertrand V, Vergez M, Morello R, Lecointre E, Duquenoy A, Cepitelli P, Boulloche J. [Systematic nutritional evaluation increases financing of hospital care in children]. Arch Pediatr. 2014 Jul;21(7):798-9. 16. IF:0.41
———————————————————————————————————————————————————
Beuselinck B, Karadimou A, Lambrechts D, Claes B, Wolter P, Couchy G, Berkers J, van Poppel H, Paridaens R, Schöffski P, Méjean A, Verkarre V, Lerut E, Joly F, Lebret T, Gravis G, Deplanque G, Descazeaud A, Leclercq NR, Molinié V, Patard JJ, Teghom C, Elaidi R, Zucman-Rossi J, Oudard S. VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib – a multicentric retrospective analysis. Acta Oncol. 2014 Jan;53(1):103-12. . IF:2.997
———————————————————————————————————————————————————
Bhora FY, Chen DJ, Detterbeck FC, Asamura H, Falkson C, Filosso PL, Giaccone G, Huang J, Kim J, Kondo K, Lucchi M, Marino M, Marom EM, Nicholson AG, Okumura M, Ruffini E, Van Schil P; Staging and Prognostic Factors Committee; Advisory Boards. The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S88-96. IF:5.282
———————————————————————————————————————————————————
Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L; French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.Rev Epidemiol Sante Publique. 2014 Apr;62(2):95-108. IF:0.656
———————————————————————————————————————————————————
Blanchart K, Paciencia M, Seguin A, Chantepie S, Du Cheyron D, Charbonneau P, Galateau-Salle F, Terzi N. Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis. Minerva Anestesiol. 2014 Jan;80(1):119-20. IF:2.134
———————————————————————————————————————————————————
Borget I, Pérol M, Pérol D, Lavolé A, Greillier L, Dô P, Westeel V, Crequit J, Léna H, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Chabaud S, Vergnenegre A, Zalcman G, Chouaïd C; IFCT-GFPC investigators. Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study. BMC Cancer. 2014 Dec 15;14:953. IF:0.635
———————————————————————————————————————————————————
Bouglé D, Morello R, Brouard J. Thyroid function and metabolic risk factors in obese youth. Changes during follow-up: a preventive mechanism? Exp Clin Endocrinol Diabetes. 2014 Oct;122(9):548-52. IF:1.76
———————————————————————————————————————————————————
Bouviez N, Lakkis Z, Lubrano J, Tuerhongjiang T, Paquette B, Heyd B, Mantion G. Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up. Langenbecks Arch Surg. 2014 Dec;399(8):1031-8.
———————————————————————————————————————————————————
Boulanger M, Bienvenu B, Marquignon MF, Letourneux M, Clin B. [Systemic sclerosis and occupational exposures: About a case in a driller-powderman.] Rev Med Interne. 2014 Dec 22. pii: S0248-8663(14)00626-2.
———————————————————————————————————————————————————
Borget I, Pérol M, Pérol D, Lavolé A, Greillier L, Dô P, Westeel V, Crequit J, Léna H, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Chabaud S, Vergnenegre A, Zalcman G, Chouaïd C; IFCT-GFPC investigators. Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study. BMC Cancer. 2014 Dec 15;14:953.
———————————————————————————————————————————————————
Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C, Tinivella M, Joly F, Jonkers C, Baxter J, Gramlich L, Chicharro L, Staun M, Van Gossum A, Lo Vullo S, Mariani L. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol. 2014 Feb;25(2):487-93. IF:7.04
———————————————————————————————————————————————————
Brachet PE, Joly F. [Recent advances in patient-related outcome in gynaecological cancer]. [Article in French] Bull Cancer. 2014 Jul-Aug;101(7-8):756-9. IF:0.604
———————————————————————————————————————————————————
Bridoux V, Moutel G, Schwarz L, Michot F, Herve C, Tuech JJ. Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals. World J Surg. 2014 Oct;38(10):2487-93. IF:2.642
———————————————————————————————————————————————————
Bridoux V, Schwarz L, Moutel G, Michot F, Herve C, Tuech JJ. Reporting of ethical requirements in phase III surgical trials. J Med Ethics. 2014 Oct;40(10):687-90. IF:1.511
———————————————————————————————————————————————————
Brugière C, Karanian-Philippe M, Comoz F, Dompmartin A, Galateau-Sallé F, Verneuil L. Two cases of aggressive nontumoral folliculotropic mycosis fungoides with visceral involvement. Br J Dermatol. 2014 Oct;171(4):899-902. IF:4.275
———————————————————————————————————————————————————
Bryere J, Dejardin O, Bouvier V, Colonna M, Guizard AV, Troussard X, Pornet C, Galateau-Salle F, Bara S, Launay L, Guittet L, Launoy G. Socioeconomic environment and cancer incidence: a French population-based study in Normandy. BMC Cancer. 2014 Feb 13;14(1):87. IF:0,635
———————————————————————————————————————————————————
Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu TE, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WE, Helwig C, Schröder A, Shepherd FA; START trial team. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2014 Jan;15(1):59-68. IF:24.725
———————————————————————————————————————————————————
Charuel A, Prevost V. [Nutritional counseling in community pharmacies within the framework of the French National Nutrition and Health Program]. Ann Pharm Fr. 2014 Sep;72(5):337-47. IF:2.923
———————————————————————————————————————————————————
Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, Lantieri O, Launoy G, Guittet L. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening. Int J Cancer. 2014 Sep 5.
———————————————————————————————————————————————————
Churg A, Allen T, Borczuk AC, Cagle PT, Galateau-Sallé F, Hwang H, Murer B, Murty VV, Ordonez N, Tazelaar HD, Wick M. Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol. 2014 Jul;38(7):990-8. IF:5.145
———————————————————————————————————————————————————
Ciappuccini R, Hardouin J, Heutte N, Vaur D, Quak E, Rame JP, Blanchard D, de Raucourt D, Bardet S. Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. Eur J Endocrinol. 2014 Aug;171(2):247-52. . IF:3.686
———————————————————————————————————————————————————
Clin B. « RecoCancerProf » Working Group, Pairon JC. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement. BMC Public Health. 2014 Nov 6; 14:1155. IF:2.321
———————————————————————————————————————————————————
Clément B, Yuille M, Zaltoukal K, Wichmann HE, Anton G, Parodi B, Kozera L, Bréchot C, Hofman P, Dagher G; EU-US Expert Group on cost recovery in biobanks. Public biobanks: calculation and recovery of costs. Sci Transl Med. 2014 Nov 5;6(261):261fs45. IF:15.843
———————————————————————————————————————————————————
Coquan E, Lasnon C, Joly F, Lefort JM, Aide N. Diuretic 18 F-FDG PET/CT for therapy monitoring in urothelial bladder cancer. Eur J Nucl Med Mol Imaging. 2014 Jun 4. IF:5.217
———————————————————————————————————————————————————
Corvol A, Balard F, Moutel G, Somme D. [Refusal of care faced by case manager from elderly persons in complex situation: cross perspectives]. [Article in French] Rev Med Interne. 2014 Jan;35(1):16-20. IF:1.074
———————————————————————————————————————————————————
Cottet V, Bouvier V, Rollot F, Jooste V, Bedenne L, Faivre J, Launoy G, Bouvier AM. Incidence and Patterns of Late Recurrences in Rectal Cancer Patients. Ann Surg Oncol. 2014 Aug 27.
———————————————————————————————————————————————————
Couraud S, Vaca-Paniagua F, Villar S, Oliver J, Schuster T, Blanché H, Girard N, Trédaniel J, Guilleminault L, Gervais R, Prim N, Vincent M, Margery J, Larivé S, Foucher P, Duvert B, Vallee M, Le Calvez-Kelm F, McKay J, Missy P, Morin F, Zalcman G, Olivier M, Souquet PJ; BioCAST/IFCT-1002 investigators. DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002. Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free. Clin Cancer Res. 2014 Sep 1;20(17):4613-24. IF:8.722
———————————————————————————————————————————————————
Coureau G, Bouvier G, Lebailly P, Fabbro-Peray P, Gruber A, Leffondre K, Guillamo JS, Loiseau H, Mathoulin-Pélissier S, Salamon R, Baldi I. Mobile phone use and brain tumours in the CERENAT case-control study. Occup Environ Med. 2014 Jul;71(7):514-22. IF:3.267
———————————————————————————————————————————————————
Crochette R, Lobbedez T, Hanoy M, Le Roy F, Potier J, Besselièvre T, Cardineau É, Landru I, Ficheux M, Ryckelynck JP, Henri P. [Extracellular hydration status and residual urinary sodium excretion in chronic hemodialysis patients: a cross-sectional multicenter study]. [Article in French] Nephrol Ther. 2014 Apr;10(2):94-100. IF:0.404
———————————————————————————————————————————————————
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE- Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014 Jan;15(1):23-34. IF:24.725
———————————————————————————————————————————————————
Dejardin O, Jones AP, Rachet B, Morris E, Bouvier V, Jooste V, Coombes E, Forman D, Bouvier AM, Launoy G. The influence of geographical access to health care and material deprivation on colorectal cancer survival: Evidence from France and England. Health Place. 2014 Nov;30:36-44. IF:2.435
———————————————————————————————————————————————————
de la Fuente V, Federman N, Fustiñana MS, Zalcman G, Romano A. Calcineurin phosphatase as a negative regulator of fear memory in hippocampus: control on nuclear factor-κB signaling in consolidation and reconsolidation. Hippocampus. 2014 Dec;24(12):1549-61.
———————————————————————————————————————————————————
de Reyniès A, Jaurand MC, Renier A, Couchy G, Hysi I, Elarouci N, Galateau-Sallé F, Copin MC, Hofman P, Cazes A, Andujar P, Imbeaud S, Petel F, Pairon JC, Le Pimpec-Barthes F, Zucman-Rossi J, Jean D. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin Cancer Res. 2014 Mar 1;20(5):1323-34. IF:8.193
———————————————————————————————————————————————————
Desgrippes R, Bouvier V, Delafosse P, Robaszkiewicz M, Molinié F, Trétarre B, Lepage C, Faivre J, Jooste V, Bouvier AM. Management of rectal cancer in France in a well-defined population. Eur J Gastroenterol Hepatol. 2014 Jul;26(7):743-7. IF:2.152
———————————————————————————————————————————————————
Deshayes S, Galateau-Sallé F, de La Blanchardière A. [Hepatic abnormality.] [Article in French] Rev Med Interne. 2014 Jul 22. pii: S0248-8663(14)00554-2. IF:1.074
———————————————————————————————————————————————————
Detterbeck FC, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Frazier AA, Giaccone G, Huang J, Kim J, Kondo K, Lucchi M, Marino M, Marom EM, Nicholson AG, Okumura M, Ruffini E, Van Schil P; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S65-72. IF:5.282
———————————————————————————————————————————————————
Dhilly M, Guillouet S, Patin D, Fillesoye F, Abbas A, Gourand F, Tirel O, Galateau F, MacKenzie ET, Dumontet C, Leporrier M, Barré L. 2-[18F]fludarabine, a novel positron emission tomography (PET) tracer for imaging lymphoma: a micro-PET study in murine models. Mol Imaging Biol. 2014 Feb;16(1):118-26. IF:2.774
———————————————————————————————————————————————————
Dubois M, Lapinte N, Villier V, Lecointre C, Roy V, Tonon MC, Gandolfo P, Joly F, Hilber P, Castel H. Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant. Neuropharmacology. 2014 Apr;79:234-48. IF:4.819
———————————————————————————————————————————————————
Dubois M, Le Joncour V, Tonon MC, Anouar Y, Proust F, Morin F, Gandolfo P, Joly F, Hilber P, Castel H. Evaluation of the impact of the cancer therapy everolimus on the central nervous system in mice. PLoS One. 2014 Dec 1;9(12):e113533. IF:3.234
———————————————————————————————————————————————————
Duchange N, Darquy S, d’Audiffret D, Callies I, Lapointe AS, Loeve B, Boespflug-Tanguy O, Moutel G. Ethical management in the constitution of a European database for leukodystrophies rare diseases. Eur J Paediatr Neurol. 2014 Sep;18(5):597-603. IF:2.301
———————————————————————————————————————————————————
Duvillard L, Ortega-Deballon P, Bourredjem A, Scherrer ML, Mantion G, Delhorme JB, Deguelte-Lardière S, Petit JM, Bonithon-Kopp C; AGARIC study group. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer. BMC Cancer. 2014 Dec 3;14:912.
———————————————————————————————————————————————————
Etain B, Guittet L, Weiss N, Gajdos V, Katsahian S. Attitudes of medical students towards conflict of interest: a national survey in France.PLoS One. 2014 Mar 26;9(3):e92858. IF:3.534
———————————————————————————————————————————————————
Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases. Am J Kidney Dis. 2014 Jan;63(1):40-8.
———————————————————————————————————————————————————
Fruchart C, Tilly H, Morschhauser F, Ghesquières H, Bouteloup M, Fermé C, Van Den Neste E, Bordessoule D, Bouabdallah R, Delmer A, Casasnovas RO, Ysebaert L, Ciappuccini R, Briere J, Gisselbrecht C. Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma. Biol Blood Marrow Transplant. 2014 Dec;20(12):1905-11.
———————————————————————————————————————————————————
Federman N, Zalcman G, de la Fuente V, Fustiñana MS, Romano A. Epigenetic mechanisms and memory strength: a comparative study. J Physiol Paris. 2014 Sep-Dec;108(4-6):278-85.
———————————————————————————————————————————————————
Gaillard S, Dupuis-Girod S, Boutitie F, Rivière S, Morinière S, Hatron PY, Manfredi G, Kaminsky P, Capitaine AL, Roy P, Gueyffier F, Plauchu H; ATERO Study Group. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost. 2014 Sep;12(9):1494-502. IF:4.984
———————————————————————————————————————————————————
Galateau-Sallé F, Gilg Soit Ilg A, Le Stang N, Brochard P, Pairon JC, Astoul P, Frenay C, Blaizot G, Chamming’s S, Ducamp S, Rousvoal T, de Quillacq A, Abonnet V, Abdalsamad I, Begueret H, Brambilla E, Capron F, Copin MC, Danel C, de Lajartre AY, Foulet-Roge A, Garbe L, Groussard O, Giusiano S, Hofman V, Lantuejoul S, Piquenot JM, Rouquette I, Sagan C, Thivolet-Bejui F, Vignaud JM, Scherpereel A, Jaurand MC, Jean D, Hainaut P, Chérié-Challine L, Goldberg M, Luce D, Imbernon E. [The French mesothelioma network from 1998 to 2013]. Ann Pathol. 2014 Feb;34(1):51-63. IF:0.291
———————————————————————————————————————————————————
Gallois E, Lamy T, Fines-Guyon M, Lobbedez T, Cattoir V. Recurrent peritoneal dialysis-related peritonitis caused by Microbacterium resistens. Diagn Microbiol Infect Dis. 2014 May;79(1):111-3. IF:2.457
———————————————————————————————————————————————————
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R; the EUROCARE Working Group. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014 Jan;15(1):35-47 IF:24,725
———————————————————————————————————————————————————
Gautier M, Boutemy J, Ivascau C, Galateau-Salle F, Labombarda F. Cardiac involvement in relapsing polychondritis. Eur Heart J. 2014 Sep 1;35(33):2241. IF:15.203
———————————————————————————————————————————————————
Girard N, Gounant V, Mennecier B, Greillier L, Cortot AB, Couraud S, Besse B, Brouchet L, Castelnau O, Ferretti GR, Frappé P, Khalil A, Lefebure P, Laurent F, Liebart S, Margery J, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; pour le groupe de travail multidisciplinaire de l’Intergroupe francophone de cancérologie thoracique, de la Société d’imagerie thoracique et du Groupe d’oncologie de langue française. [Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]. Rev Mal Respir. 2014 Jan;31(1):91-103. IF:0.488
———————————————————————————————————————————————————
Gravis G, Boher JM, Fizazi K, Joly F, Priou F, Marino P, Latorzeff I, Delva R, Krakowski I, Laguerre B, Walz J, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, Kouri CE, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M, Oudard S. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model. Eur Urol. 2014 Sep 29. pii: S0302-2838(14)00959-2. IF:13.938
———————————————————————————————————————————————————
Gravis G, Marino P, Joly F, Oudard S, Priou F, Esterni B, Latorzeff I, Delva R, Krakowski I, Laguerre B, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M, Fizazi K. Patients’ self-assessment versus investigators’ evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15). Eur J Cancer. 2014 Mar;50(5):953-62. IF:5.417
———————————————————————————————————————————————————
Haustraete E, Campbell K, Magnier R, Zalcman G, Bergot É. [Interest of collapse therapy in pulmonary extensively drug-resistant tuberculosis]. [Article in French] Rev Pneumol Clin. 2014 Aug;70(4):240-4. IF:0.248
———————————————————————————————————————————————————
Heutte N, Plisson L, Lange M, Prevost V, Babin E. Quality of life tools in head and neck oncology. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Feb;131(1):33-47. IF:0.822
———————————————————————————————————————————————————
Houédé N, Pulido M, Mourey L, Joly F, Ferrero JM, Bellera C, Priou F, Lalet C, Laroche-Clary A, Raffin MC, Ichas F, Puech A, Piazza PV. A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer. Oncologist. 2014 Dec;19(12):1227-8. IF:4.865
———————————————————————————————————————————————————
Husain AN, Mirza MK, Gibbs A, Hiroshima K, Chi Y, Boumendjel R, Stang N, Krausz T, Galateau-Salle F. How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study. Lung Cancer. 2014 Mar;83(3):324-8. IF:3.958
———————————————————————————————————————————————————
Jégu J, Colonna M, Daubisse-Marliac L, Trétarre B, Ganry O, Guizard AV, Bara S, Troussard X, Bouvier V, Woronoff AS, Velten M. The effect of patient characteristics on second primary cancer risk in France. BMC Cancer. 2014 Feb 15;14(1):94. IF:3.319
———————————————————————————————————————————————————
Joly F, McAlpine J, Nout R, Åvall-Lundqvist E, Shash E, Friedlander M; Gynaecologic Cancer InterGroup (GCIG). Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action! Int J Gynecol Cancer. 2014 Nov;24(9):1693-9. IF:1.958
———————————————————————————————————————————————————
Kondo K, Van Schil P, Detterbeck FC, Okumura M, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kim J, Lucchi M, Marino M, Marom EM, Nicholson AG, Ruffini E; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S81-7. IF:5.282
———————————————————————————————————————————————————
Labombarda F, Leport M, Morello R, Ribault V, Kauffman D, Brouard J, Pellissier A, Maragnes P, Manrique A, Milliez P, Saloux E. Longitudinal left ventricular strain impairment in type 1 diabetes children and adolescents: a 2D speckle strain imaging study. Diabetes Metab. 2014 Sep;40(4):292-8. IF:2,845
———————————————————————————————————————————————————
Lacourt A, Gramond C, Rolland P, Ducamp S, Audignon S, Astoul P, Chamming’s S, Gilg Soit Ilg A, Rinaldo M, Raherison C, Galateau-Salle F, Imbernon E, Pairon JC, Goldberg M, Brochard P. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax. 2014 Jun;69(6):532-9. IF:8.29
———————————————————————————————————————————————————
Lamy T, Henri P, Lobbedez T, Comby E, Ryckelynck JP, Ficheux M. Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal. Blood Purif. 2014;37(2):93-8.
———————————————————————————————————————————————————
Lange M, Rigal O, Clarisse B, Giffard B, Sevin E, Barillet M, Eustache F, Joly F.Cancer Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. Treat Rev. 2014 Jul;40(6):810-7
———————————————————————————————————————————————————
Lange M, Giffard B, Noal S, Rigal O, Kurtz JE, Heutte N, Lévy V, Allouache D, Rieux C, Le Fel J, Daireaux A, Clarisse B, Veyret C, Barthélémy P, Longato N, Eustache F, Joly F. Baseline cognitive functions among elderly patients with localized breast cancer. European Journal of Cancer (2014). IF:4,819
———————————————————————————————————————————————————
Laurent F, Paris C, Ferretti GR, Beigelman C, Montaudon M, Latrabe V, Jankowski A, Badachi Y, Clin B, Gislard A, Letourneux M, Luc A, Schorlé E, Brochard P, Ameille J, Pairon JC. Inter-reader agreement in HRCT detection of pleural plaques and asbestosis in participants with previous occupational exposure to asbestos. Occup Environ Med. 2014 Dec;71(12):865-70. IF:3,234
———————————————————————————————————————————————————
Lemaire A, Cuttone F, Caprio S, Massetti M, Galateau-Salle F. Giant-cell aortitis: an unusual case of Bentall operation. Asian Cardiovasc Thorac Ann. 2014 Mar;22(3):342-4.
———————————————————————————————————————————————————
Lemarchand C, Tual S, Levêque-Morlais N, Perrier S, Guizard AV, Velten M, Rigaud E, Baldi I, Lebailly P. Prostate cancer risk among French farmers in the AGRICAN cohort. Occup Environ Med. 2014 Jun;71 Suppl 1:A86-7. IF:1.797
———————————————————————————————————————————————————
Lepailleur A, Bureau R, Halm-Lemeille MP, Bouquet M, Pecquet R, Paris-Soubayrol C, Goff JL, André V, Lecluse Y, Lebailly P, Maire MA, Vasseur P. Assessment of the genotoxic and carcinogenic potentials of 3-aminothiophene derivatives using in vitro and in silico methodologies. J Appl Toxicol. 2014 Jul;34(7):775-86. IF:3.174
———————————————————————————————————————————————————
Le Palud P, Cattoir V, Malbruny B, Magnier R, Campbell K, Oulkhouir Y, Zalcman G, Bergot E. Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. BMC Pulm Med. 2014 Aug 12;14:13. IF:2.449
———————————————————————————————————————————————————
Lerouge D, Rivière A, Dansin E, Chouaid C, Dujon C, Schott R, Lavole A, Le Pennec V, Fabre E, Crequit J, Martin F, Dehette S, Fournel P, Precheur-Agulhon B, Lartigau E, Zalcman G. A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer. BMC Cancer. 2014 Mar 30;14:231. IF:3.319
———————————————————————————————————————————————————
Levêque-Morlais N, Tual S, Clin B, Adjemian A, Baldi I, Lebailly P. The AGRIculture and CANcer (AGRICAN) cohort study: enrollment and causes of death for the 2005-2009 period. Int Arch Occup Environ Health. 2014 Mar 6.
———————————————————————————————————————————————————
Labombarda F, Leport M, Morello R, Ribault V, Kauffman D, Brouard J, Pellissier A, Maragnes P, Manrique A, Milliez P, Saloux E. Longitudinal left ventricular strain impairment in type 1 diabetes children and adolescents: a 2D speckle strain imaging study. Diabetes Metab. 2014 Sep;40(4):292-8.
———————————————————————————————————————————————————
Le Palud P, Cattoir V, Malbruny B, Magnier R, Campbell K, Oulkhouir Y, Zalcman G, Bergot E. Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. BMC Pulm Med. 2014 Aug 12;14:137.
———————————————————————————————————————————————————
McAlpine JN, Greimel E, Brotto LA, Nout RA, Shash E, Avall-Lundqvist E, Friedlander ML, Joly F; Gynecologic Cancer InterGroup (GCIG). Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012. Int J Gynecol Cancer. 2014 Nov;24(9):1686-92. IF:1.958
———————————————————————————————————————————————————
Menahem B, Guittet L, Mulliri A, Alves A, Lubrano J. Pancreaticogastrostomy Is Superior to Pancreaticojejunostomy for Prevention of Pancreatic Fistula After Pancreaticoduodenectomy: An Updated Meta-analysis of Randomized Controlled Trials. Ann Surg. 2014 Jun 27. IF:7.188
———————————————————————————————————————————————————
Minicozzi P, Bouvier AM, Faivre J, Sant M; the study working group. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients.Dig Liver Dis. 2014 Apr 15. IF:2.889
———————————————————————————————————————————————————
Molinié F, Vanier A, Woronoff AS, Guizard AV, Delafosse P, Velten M, Daubisse-Marliac L, Arveux P, Tretarre B. Trends in breast cancer incidence and mortality in France 1990-2008. Breast Cancer Res Treat. 2014 Aug;147(1):167-75. IF:4.198
———————————————————————————————————————————————————
Mortamet G, Morello R, Jokic M, Vabret A, Leroux M, Brouard 6, Dina J. [Winter viral ecology in a pediatric intensive care unit: A prospective study.] Arch Pediatr. 2014 Dec 19. pii: S0929-693X(14)00518-1.
———————————————————————————————————————————————————
Mourad A, Deuffic-Burban S, Ganne-Carrié N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology. 2014 Apr;59(4):1471-81. IF:11.19
———————————————————————————————————————————————————
Moutel G, Duchange N, Darquy S, de Montgolfier S, Papin-Lefebvre F, Jullian O, Viguier J, Sancho-Garnier H; GRED French National Cancer Institute. Women’s participation in breast cancer screening in France–an ethical approach. BMC Med Ethics. 2014 Aug 16;15:64. IF:1.495
———————————————————————————————————————————————————
Nicholson AG, Detterbeck FC, Marino M, Kim J, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kondo K, Lucchi M, Marom EM, Okumura M, Ruffini E, Van Schil P; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S73-80. IF:5.282
———————————————————————————————————————————————————
Novello S, Besse B, Felip E, Barlesi F, Mazieres J, Zalcman G, von Pawel J, Reck M, Cappuzzo F, Ferry D, Carcereny E, Santoro A, Garcia-Ribas I, Scagliotti G, Soria JC. A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer. Ann Oncol. 2014 Nov;25(11):2156-62. IF:6.578
———————————————————————————————————————————————————
Ortega-Deballon P, Duvillard L, Scherrer ML, Deguelte-Lardière S, Bourredjem A, Petit JM, Bonithon-Kopp C; AGARIC Study group. Preoperative adipocytokines as a predictor of surgical infection after colorectal surgery: a prospective survey. Int J Colorectal Dis. 2014 Jan;29(1):23-9.
———————————————————————————————————————————————————
Ouédraogo S, Dabakuyo-Yonli TS, Roussot A, Pornet C, Sarlin N, Lunaud P, Desmidt P, Quantin C, Chauvin F, Dancourt V, Arveux P. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France. Prev Med. 2014 Jun;63:103-8.IF:3.086
———————————————————————————————————————————————————
Papin-Lefebvre F, Moutel G, Duchange N, de Montgolfier S, Sancho-Garnier H, Jullian O, Viguier J; GRED/INCa. [Breast cancer screening program in France: for optimization of the information]. [Article in French] Rev Epidemiol Sante Publique. 2014 Apr;62(2):109-17 IF:0.592
———————————————————————————————————————————————————
Pham AD, Névéol A, Lavergne T, Yasunaga D, Clément O, Meyer G, Morello R, Burgun A. Natural language processing of radiology reports for the detection of thromboembolic diseases and clinically relevant incidental findings. BMC Bioinformatics. 2014 Aug 7;15:266. IF:2.672
———————————————————————————————————————————————————
Pairon JC, Andujar P, Rinaldo M, Ameille J, Brochard P, Chamming’s S, Clin B, Ferretti G, Gislard A, Laurent F, Luc A, Wild P, Paris C. Asbestos exposure, pleural plaques, and the risk of death from lung cancer. Am J Respir Crit Care Med. 2014 Dec 15;190(12):1413-20. IF:11.986
———————————————————————————————————————————————————
Pornet C, Denis B, Perrin P, Gendre I, Launoy G. Predictors of adherence to repeat fecal occult blood test in a population-based colorectal cancer screening program. Br J Cancer. 2014 Nov 25;111(11):2152-5. IF:4.817
———————————————————————————————————————————————————
Prevost V, Joubert C, Heutte N, Babin E. Assessment of nutritional status and quality of life in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Apr;131(2):113-20. IF:0.822
———————————————————————————————————————————————————
Quoix E, Westeel V, Moreau L, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Sennelart H, Tredaniel J, Mennecier B, Morin F, Baudrin L, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique. Second-line therapy in elderly patients with advanced nonsmall cell lung cancer. Eur Respir J. 2014 Jan;43(1):240-9. IF:7.125
———————————————————————————————————————————————————
Revel L, Lubrano J, Badet N, Manzoni P, Degano SV, Delabrousse E. Preoperative diagnosis of gangrenous acute cholecystitis: usefulness of CEUS. Abdom Imaging. 2014 Dec;39(6):1175-81.
———————————————————————————————————————————————————
Reznik Y, Morello R, Zenia A, Morera J, Rod A, Joubert M. Autonomy of patients with type 2 diabetes with an insulin pump device: is it predictable? J Diabetes Sci Technol. 2014 Jul;8(4):760-5.
———————————————————————————————————————————————————
Robard L, Louis MY, Blanchard D, Babin E, Delanian S. Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Dec;131(6):333-8. IF:0.822
———————————————————————————————————————————————————
Schagen SB, Klein M, Reijneveld JC, Brain E, Deprez S, Joly F, Scherwath A, Schrauwen W, Wefel JS. Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions. EJC Suppl. 2014 Jun;12(1):29-40. IF:5.417
———————————————————————————————————————————————————
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Iyer S, Reisman A, Wilner KD, Tursi J, Blackhall F; PROFILE 1014 Investigators. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014 Dec 4;371(23):2167-77. IF:54.42
———————————————————————————————————————————————————
Stockler MR, Hilpert F, Friedlander M, King MT, Wenzel L, Lee CK, Joly F, de Gregorio N, Arranz JA, Mirza MR, Sorio R, Freudensprung U, Sneller V, Hales G, Pujade-Lauraine E. Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. J Clin Oncol. 2014 May 1;32(13):1309-16. IF:18.428
———————————————————————————————————————————————————
Tallet A, Nault JC, Renier A, Hysi I, Galateau-Sallé F, Cazes A, Copin MC, Hofman P, Andujar P, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D. Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma. Oncogene. 2014 Jul 10;33(28):3748-52. IF:8.459
———————————————————————————————————————————————————
Tripey V, Monsallier JM, Morello R, Hamel-Desnos C. French sclerotherapy and compression: Practice patterns. Phlebology. 2014 Oct 8.
———————————————————————————————————————————————————
Vallet F, Guillaume E, Dejardin O, Guittet L, Bouvier V, Mignon A, Berchi C, Salinas A, Launoy G, Christophe V. Influence of a screening navigation program on social inequalities in health beliefs about colorectal cancer screening. J Health Psychol. 2014 Dec 30. IF: 1.88
———————————————————————————————————————————————————
van der Kaaij MA, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Eghbali H, Brice P, Smit WG, Sebban C, Doorduijn JK, Roesink JM, Gaillard I, Coiffier B, Lybeert ML, Casasnovas O, André M, Raemaekers JM, Henry-Amar M, Kluin-Nelemans JC; European Organisation for Research and Treatment of Cancer Lymphoma Group and the Groupe d’Étude des Lymphomes de l’Adulte. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod. 2014 Mar;29(3):525-33. IF:4.585
———————————————————————————————————————————————————
Veracini L, Grall D, Schaub S, Beghelli-de la Forest Divonne S, Etienne-Grimaldi MC, Milano G, Bozec A, Babin E, Sudaka A, Thariat J, Van Obberghen-Schilling E. Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas. Oncotarget. 2014 Dec 26.
———————————————————————————————————————————————————
Vergote IB, Jimeno A, Joly F, Katsaros D, Coens C, Despierre E, Marth C, Hall M, Steer CB, Colombo N, Lesoin A, Casado A, Reinthaller A, Green J, Buck M, Ray-Coquard I, Ferrero A, Favier L, Reed NS, Curé H, Pujade-Lauraine E. Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study. J Clin Oncol. 2014 Feb 1;32(4):320-6. IF:17.879
———————————————————————————————————————————————————
Westeel V, Quoix E, Zalcman G, Milleron B. Reply to letter. Eur J Cancer. 2014 Feb;50(3):678. IF:4.819
———————————————————————————————————————————————————
Wislez M, Barlesi F, Besse B, Mazières J, Merle P, Cadranel J, Audigier-Valette C, Moro-Sibilot D, Gautier-Felizot L, Goupil F, Renault A, Quoix E, Souquet PJ, Madroszyck A, Corre R, Pérol D, Morin F, Zalcman G, Soria JC. Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE. J Clin Oncol. 2014 Apr 20;32(12):1256-61. IF:17.879
